Immunotherapy Archives

World’s first lung cancer vaccine given to patient in UK as human trials begin

HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known.

by HealthQuill
August 23, 2024
0 Comments

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare form of blood cancer that affects the skin.

Drugs Health Pharma

Citius’s blood cancer drug gets US regulatory body’s clearance

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.

by HealthQuill
August 9, 2024
0 Comments

Merck has stopped an end-stage combination immunotherapy trial for a lung cancer condition, following recommendations of an independent data monitoring committee, which indicated the drug wouldn’t succeed.

Drugs Health Pharma

Merck halts small cell lung cancer immunotherapy drug trial

Merck has stopped an end-stage combination immunotherapy trial for a lung cancer condition, following recommendations of an independent data monitoring committee, which indicated.

by HealthQuill
August 8, 2024
0 Comments

Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer responds to immunotherapy drugs.

Drugs Health Pharma

NIH researchers make AI tool to read cancer responses to immunotherapy

Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer.

by HealthQuill
June 4, 2024
0 Comments

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.

Drugs Medical Pharma

Merck’s Keytruda receives FDA nod for cervical cancer treatment

HQ Team January 13, 2024: The U.S. Food and Drug Administration (FDA) has granted approval for the expanded use of Merck & Co’s.

by HealthQuill
January 13, 2024
0 Comments

India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to treat leukaemia and cancer of the lymphatic system.

Drugs Health Pharma

ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India

HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.

by HealthQuill
October 16, 2023
0 Comments

https://investors.immatics.com/news-releases/news-release-details/moderna-and-immatics-announce-strategic-multi-platform

Drugs Health Pharma

Moderna, Immatics join hands to hunt for cancer therapies using mRNA, AI

HQ Team September 11, 2023: Moderna Inc. announced a pact with Immatics NV, a clinical-stage biopharmaceutical company, to develop cancer therapies using a.

by HealthQuill
September 11, 2023
0 Comments

Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to evaluate the combination of the company's breast cancer vaccine with Merck’s Keytruda (pembrolizumab) immunotherapy.

Drugs Health Pharma

Anixa to conduct breast cancer trials with Merck’s Keytruda therapy

HQ Team August 7, 2023: Anixa Biosciences, Inc., announced that its partner Cleveland Clinic has begun enrolling subjects in a treatment arm to.

by HealthQuill
August 8, 2023
0 Comments

US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from eventual revenue loss as patents on its cancer immunotherapy Keytruda expires by the end of the decade.

Drugs Pharma

Merck to acquire Prometheus for $10.8 billion to step up immunology presence

HQ Team April 17, 2023: US-based Merck will buy Prometheus Biosciences for about 10.8 billion to shore up its immunology portfolio to shield itself from.